Related Experiment Video
Updated: Feb 27, 2026

Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells
Published on: May 16, 2019
Zinc: a metallic shield against cardiac inflammation
Kemmoy Lattibeaudiere1, Shelly McFarlane2, Marvin Reid2
1School of Natural and Applied Sciences, University of Technology, Kingston, Jamaica.
Maintaining adequate zinc (Zn) levels is crucial for immune function and reducing oxidative stress. Optimal zinc status may help prevent and manage cardiac inflammatory diseases by supporting cardiovascular resilience.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Medicine
Background:
- Zinc (Zn) is an essential trace element vital for over 10% of human proteins.
- Zn plays key roles in immune regulation, inflammation control, and redox signaling.
- Low Zn status is linked to impaired immunity and increased oxidative stress, contributing to cardiac inflammatory diseases (CIDs).
Purpose of the Study:
- To review the biochemical, immunological, and therapeutic roles of zinc in cardiac inflammation.
- To highlight zinc's potential as an intervention for CIDs.
Main Methods:
- Literature review synthesizing current knowledge on zinc's functions in the cardiovascular system.
- Analysis of zinc's role in redox signaling, antioxidant defense, and inflammatory pathways.
Main Results:
- Zinc protects against oxidation and acts as a redox-sensitive messenger via the "Redox Zinc Switch".
- In the cardiovascular system, zinc influences antioxidant defense, cytokine regulation, and membrane repair.
- Emerging evidence suggests zinc supplementation can mitigate myocardial inflammation and cardiac remodeling.
Conclusions:
- Optimal zinc levels, achieved through diet or supplementation, are a promising strategy to reduce the incidence and impact of CIDs.
- Maintaining sufficient zinc is vital for cardiovascular resilience, particularly in at-risk populations.
- Zinc supplementation may improve outcomes in oxidative stress-driven heart conditions.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
07:55Author Spotlight: Exploring Cellular Zinc Regulation Through ZnT1 Functionality
Published on: June 2, 2023
Related Concept Videos
Myocarditis III: Medical Management
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Rheumatic Heart Disease III: Medical Management
Corrosion
Myocarditis I: Introduction
Atherosclerosis III: Management